Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina

被引:121
作者
Mrudula, T. [1 ]
Suryanarayana, P. [1 ]
Srinivas, P. N. B. S. [1 ]
Reddy, G. Bhanuprakash [1 ]
机构
[1] Indian Council Med Res, Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India
关键词
curcumin; turmeric; VEGF; diabetes; rat; retina;
D O I
10.1016/j.bbrc.2007.07.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic retinopathy is one of the most devastating microvascular complications of long standing type I and type 2 diabetes. Neovascularization stimulated by hyperglycemia-mediated induction of vascular endothelial growth factor (VEGF) has been implicated in the pathogenesis. Various small molecules have been investigated for their ability to inhibit angiogenesis. In this study, we evaluated whether curcumin and its dietary source turmeric can inhibit VEGF expression in strepotzotocin (STZ)-induced diabetic rat retina. Diabetes was induced in 3-month-old male WNIN rats by a single intraperitoneal injection of STZ. After induction, one group of diabetic rats were fed only the AIN-93 diet and the rest of the groups were fed with AIN-93 diet containing 0.002% or 0.01% curcumin or 0.5% turmeric for a period of 8 weeks. The control rats received sham injection and fed on the AIN-93 diet. At the end of 8 weeks animals were sacrificed and retina was dissected. The VEGF expression was analyzed by both real time PCR and immunoblotting. There was an increase in VEGF expression in diabetic retina as compared to control retina at both transcript and protein level. Notably, feeding of curcumin and turmeric to diabetic rats inhibited expression of VEGF. This study highlights the importance of biologically active compounds derived from dietary agents that could be explored further for the prevention and/or treatment of diabetic retinopathy. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:528 / 532
页数:5
相关论文
共 34 条
  • [1] INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY
    ADAMIS, AP
    MILLER, JW
    BERNAL, MT
    DAMICO, DJ
    FOLKMAN, J
    YEO, TK
    YEO, KT
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) : 445 - 450
  • [2] UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes
    Adler, AI
    Stevens, RJ
    Neil, A
    Stratton, IM
    Boulton, AJM
    Holman, RR
    [J]. DIABETES CARE, 2002, 25 (05) : 894 - 899
  • [3] Molecular targets of dietary agents for prevention and therapy of cancer
    Aggarwal, BB
    Shishodia, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) : 1397 - 1421
  • [4] SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS
    AIELLO, LP
    PIERCE, EA
    FOLEY, ED
    TAKAGI, H
    CHEN, H
    RIDDLE, L
    FERRARA, N
    KING, GL
    SMITH, LEH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) : 10457 - 10461
  • [5] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [6] Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
    Ambati, J
    Chalam, KV
    Chawla, DK
    DAngio, CT
    Guillet, EG
    Rose, SJ
    Vanderlinde, RE
    Ambati, BK
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (09) : 1161 - 1166
  • [7] Bae MK, 2006, ONCOL REP, V15, P1557
  • [8] Biochemistry and molecular cell biology of diabetic complications
    Brownlee, M
    [J]. NATURE, 2001, 414 (6865) : 813 - 820
  • [9] Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin
    Chen, YR
    Tan, TH
    [J]. ONCOGENE, 1998, 17 (02) : 173 - 178
  • [10] Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: A mechanism of tumor growth inhibition
    Choi, Hyunsung
    Chun, Yang-Sook
    Kim, Seung-Won
    Kim, Myung-Suk
    Park, Jong-Wan
    [J]. MOLECULAR PHARMACOLOGY, 2006, 70 (05) : 1664 - 1671